药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Insulin detemir
Lorpiprazole
The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Lorpiprazole.
Insulin detemir
Berotralstat
The metabolism of Levomilnacipran can be decreased when combined with Berotralstat.
Insulin detemir
Asunaprevir
The metabolism of Levomilnacipran can be decreased when combined with Asunaprevir.
Insulin detemir
Lumefantrine
The metabolism of Levomilnacipran can be decreased when combined with Lumefantrine.
Insulin detemir
Rhein
The metabolism of Levomilnacipran can be decreased when combined with Rhein.
Insulin detemir
Manidipine
The metabolism of Levomilnacipran can be decreased when combined with Manidipine.
Insulin detemir
Phenylbutyric acid
The metabolism of Levomilnacipran can be decreased when combined with Phenylbutyric acid.
Insulin detemir
Sulfaphenazole
The metabolism of Levomilnacipran can be decreased when combined with Sulfaphenazole.
Insulin detemir
Rucaparib
The metabolism of Levomilnacipran can be decreased when combined with Rucaparib.
Insulin detemir
Rolapitant
The metabolism of Levomilnacipran can be decreased when combined with Rolapitant.
Insulin detemir
Ritanserin
The metabolism of Ritanserin can be decreased when combined with Levomilnacipran.
Insulin detemir
Dosulepin
The metabolism of Dosulepin can be decreased when combined with Levomilnacipran.
Insulin detemir
Vilazodone
The metabolism of Levomilnacipran can be decreased when combined with Vilazodone.
Insulin detemir
Lorcaserin
The metabolism of Levomilnacipran can be decreased when combined with Lorcaserin.
Insulin detemir
Ubidecarenone
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Ubidecarenone.
Insulin detemir
Clinafloxacin
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Clinafloxacin.
Insulin detemir
Cibenzoline
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Cibenzoline.
Insulin detemir
Lanreotide
The risk or severity of hypoglycemia can be increased when Lanreotide is combined with Levomilnacipran.
Insulin detemir
Pasireotide
The risk or severity of hypoglycemia can be increased when Pasireotide is combined with Levomilnacipran.
Insulin detemir
Empagliflozin
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Empagliflozin.